Номе
News
Companies
Magazine
Search Engine
Promotion
Contact
Русский
Search
Search
Home
News
Magazine
Companies
Events
Search Engine
Promotion
Contact
Русский
Pharmaceutical Industry Information Portal
Home
News
Magazine
Companies
Events
Search Engine
Promotion
Contact
Русский
Search
Home
News
News
World Pharma News
Catalent Plans Multi-Phase, $100 Million Expansion of Italian Facility
Techno
-
21.07.2021
Catalent’s Anagni site is a world-class biologics and oral dose manufacturing facility that specializes in late-stage and commercial product launches.
Regulatory News
Appeal supported FAS in case of orthopedic products cartel
Techno
-
21.07.2021
The FAS Russia has sent the case materials to law enforcements for making a decision on initiating criminal cases against company officials.
Manufacturers News
Sputnik V vaccine approved for use in Chile
Techno
-
21.07.2021
Thus
Sputnik V
is now approved in 69 countries with total population exceeding 3.7 billion people - nearly half of the global population.
Manufacturers News
EAEU GMP Certificate issued to Pharmasyntez
Techno
-
19.07.2021
The Pharmasyntez Group of Companies also was one of the first in Russia to be granted a Marketing Authorization under the EAEU rules.
World Pharma News
Thermo Fisher Scientific Opens cGMP Plasmid DNA Manufacturing Facility
Techno
-
18.07.2021
The 67,000-square-foot facility, located on Thermo Fisher's Carlsbad campus, is part of an investment strategy to ensure customers can reliably meet growing global demand for cell and gene therapies and vaccines.
Regulatory News
Sputnik V vaccine against coronavirus authorized in Nigeria
Techno
-
16.07.2021
Total population of all countries where Sputnik V is approved for use now exceeds 3.7 billion people, which is nearly half of the global population.
1
...
92
93
94
...
113
Page 93 of 113
Search
Expert Articles
GMP-Inspections of veterinary manufacturers in the second quarter of 2025
GMP-inspections of veterinary manufacturers in the first quarter of 2025
GMP-inspections of veterinary manufacturers in the fourth quarter of 2024